Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription Articles published in J Virol Methods Retrieve available abstracts of 215 articles: HTML format

Single Articles

November 2023
1. BOUJEMAA S, Suri GS, Kaur G
   Diagnostic evaluation of Panbio antigen rapid diagnostic test for SARS-CoV-2: A systematic review and meta-analysis.
   J Virol Methods. 2023;321:114811.
   PubMed     Abstract available
   
   
   
2. JASSOY C, Biemann R, Honemann M
   Low BAU/ml values with 4 of 5 SARS CoV-2 spike-specific monoclonal antibodies in the Roche Elecsys antibody assay.
   J Virol Methods. 2023;321:114786.
   PubMed     Abstract available
   
   
   October 2023
3. DI DYW, Li B, Jeon MK, Yan T, et al
   Comparing solid-based concentration methods for rapid and efficient recovery of SARS-CoV-2 for wastewater surveillance.
   J Virol Methods. 2023;320:114790.
   PubMed     Abstract available
   
   
   
4. DERIN DC, Gultekin E, Taskin II, Otlu B, et al
   Designing of rapid assay for the detection of RdRp/Orf1ab specific to SARS-CoV-2.
   J Virol Methods. 2023;320:114774.
   PubMed     Abstract available
   
   
   September 2023
5. FLINCK H, Aittoniemi J
   Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.
   J Virol Methods. 2023;319:114758.
   PubMed     Abstract available
   
   
   
6. EPTAMINITAKI GC, Parakatselaki ME, Petroulaki C, Marinopoulou D, et al
   Rapid identification of SARS-CoV-2 variants: Validation of the simplexa SARS-CoV-2 variant direct assay.
   J Virol Methods. 2023;319:114759.
   PubMed     Abstract available
   
   
   July 2023
7. NOH EB, Heo GB, Lee KN, Kang YM, et al
   Subtype specific virus enrichement with immunomagnetic separation method followed by NGS unravels the mixture of H5 and H9 avian influenza virus.
   J Virol Methods. 2023;320:114773.
   PubMed     Abstract available
   
   
   
8. DE SOUZA ANDRADE A, Freitas EF, de Castro Barbosa E, Guimaraes NR, et al
   Potential use of high-resolution melting analyses for SARS-CoV-2 genomic surveillance.
   J Virol Methods. 2023;317:114742.
   PubMed     Abstract available
   
   
   
9. AHMED W, Smith WJM, Sirikanchana K, Kitajima M, et al
   Influence of membrane pore-size on the recovery of endogenous viruses from wastewater using an adsorption-extraction method.
   J Virol Methods. 2023;317:114732.
   PubMed     Abstract available
   
   
   
10. PILCHOVA V, Prajeeth CK, Jendrny P, Twele F, et al
    beta-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training.
    J Virol Methods. 2023;317:114733.
    PubMed     Abstract available
    
    
    June 2023
11. LAMOTTE LA, Tafforeau L
    Generation of an A549 ISRE-luciferase stable cell line.
    J Virol Methods. 2023;316:114731.
    PubMed     Abstract available
    
    
    
12. FILIPPATOS F, Tatsi EB, Papagiannopoulos C, Syriopoulou V, et al
    Comparison of a rapid fluorescence immunochromatographic test with an enzyme-linked immunosorbent assay for measurement of SARS-CoV-2 spike protein antibody neutralizing activity.
    J Virol Methods. 2023;316:114728.
    PubMed     Abstract available
    
    
    
13. HEAPS AL, Sobolewski MD, Jacobs JL, Gordon KC, et al
    Rapid determination of SARS-CoV-2 antibody neutralization titer using Bio-Rad Bio-Plex correlates strongly with pseudovirus-determined neutralization titer.
    J Virol Methods. 2023;316:114726.
    PubMed     Abstract available
    
    
    
14. ABD-ELDAIM MM, Maarouf M, Potgieter L, Kania SA, et al
    Amino acid variations of the immuno-dominant domain of respiratory syncytial virus attachment glycoprotein (G) affect the antibody responses In BALB/c mice.
    J Virol Methods. 2023;316:114712.
    PubMed     Abstract available
    
    
    
15. CROWE A, Lorenzo YP, Jardine D, Visvanathan K, et al
    Evaluation of a novel anterior nasal swab for the detection of SARS-CoV-2.
    J Virol Methods. 2023;316:114713.
    PubMed     Abstract available
    
    
    
16. EFFAH K, Agbemafle I, Essel NO, Amuah JE, et al
    Comparison of the AmpFire and MA-6000 polymerase chain reaction platforms for high-risk human papillomavirus testing in cervical precancer screening.
    J Virol Methods. 2023;316:114709.
    PubMed     Abstract available
    
    
    May 2023
17. DAKHAVE M, Gadekar S, Malekar A, Wankhede G, et al
    'CoviSwift(TM'): A point-of-care RT-PCR device for SARS-CoV-2 and its variant detection.
    J Virol Methods. 2023;315:114714.
    PubMed     Abstract available
    
    
    
18. ANDRADE IA, Franca LV, Kauffmann CM, Maeda MHK, et al
    Practical use of tobravirus-based vector to produce SARS-CoV-2 antigens in plants.
    J Virol Methods. 2023;315:114710.
    PubMed     Abstract available
    
    
    
19. SANCHEZ-PACHECO UA, Bahena-Mondragon BM, Hernandez-Piedras FR, Soria-Osorio R, et al
    Development of a validated molecular analytical method to determine the viral safety of F(AB )(2) products: A novel application for a well-known technique.
    J Virol Methods. 2023;315:114694.
    PubMed     Abstract available
    
    
    April 2023
20. KAMI W, Kinjo T, Hashioka H, Arakaki W, et al
    Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detection.
    J Virol Methods. 2023;314:114692.
    PubMed     Abstract available
    
    
    
21. AOKI A, Adachi H, Mori Y, Ito M, et al
    A modified high-resolution melting-based assay (HRM) to identify the SARS-CoV-2 N501Y variant.
    J Virol Methods. 2023;314:114678.
    PubMed     Abstract available
    
    
    March 2023
22. HORLYCK S, Nielsen SH, Gress T, Schneider U, et al
    Combined nasal- and oropharyngeal self-swab provides equivalent performance compared to professionally collected oropharyngeal swabs in detecting SARS-CoV-2 in a real-life setting.
    J Virol Methods. 2023;313:114667.
    PubMed     Abstract available
    
    
    February 2023
23. SAKALAR C, Erturk M
    Inactivation of airborne SARS-CoV-2 by thyme volatile oil vapor phase.
    J Virol Methods. 2023;312:114660.
    PubMed     Abstract available
    
    
    
24. JORGENSEN TS, Pedersen MS, Blin K, Kuntke F, et al
    SpikeSeq: A rapid, cost efficient and simple method to identify SARS-CoV-2 variants of concern by Sanger sequencing part of the spike protein gene.
    J Virol Methods. 2023;312:114648.
    PubMed     Abstract available
    
    
    January 2023
25. AUER A, Panzarin V, Monne I, Crimaudo M, et al
    Comparative Assessment of Lyophilized and wet Reagents for the Molecular Detection of H5N1 High Pathogenic Avian Influenza Virus and H9N2 Low Pathogenic Avian Influenza Virus.
    J Virol Methods. 2023 Jan 30:114686. doi: 10.1016/j.jviromet.2023.114686.
    PubMed     Abstract available
    
    
    
26. MCMINN BR, Korajkic A, Pemberton AC, Kelleher J, et al
    Assessment of two volumetrically different concentration approaches to improve sensitivities for SARS-CoV-2 detection during wastewater monitoring.
    J Virol Methods. 2023;311:114645.
    PubMed     Abstract available
    
    
    November 2022
27. MOSSCROP L, Watber P, Elliot P, Cooke G, et al
    Evaluation of the impact of pre-analytical conditions on sample stability for the detection of SARS-CoV-2 RNA.
    J Virol Methods. 2022;309:114607.
    PubMed     Abstract available
    
    
    
28. WANG S, Wu Y, Wang Y, Chen Z, et al
    Potential of antibody pair targeting conserved antigenic sites in diagnosis of SARS-CoV-2 variants infection.
    J Virol Methods. 2022;309:114597.
    PubMed     Abstract available
    
    
    October 2022
29. SMITH M, El Bouzidi K, Bengen S, Cohen A, et al
    Potential pitfalls in analysing a SARS-CoV-2 RT-PCR assay and how to standardise data interpretation.
    J Virol Methods. 2022;308:114589.
    PubMed     Abstract available
    
    
    
30. DOS SANTOS CARNEIRO M, Volpato FCZ, Wink PL, Pereira DC, et al
    Evaluation of filter paper to transport oro/nasopharyngeal samples to detect SARS-CoV-2 by RT-qPCR.
    J Virol Methods. 2022;308:114587.
    PubMed     Abstract available
    
    
    September 2022
31. MATEFO L, Cloete VV, Armand BP, Dominique G, et al
    Validation of laboratory developed serology assays for detection of IgG antibody to severe acute respiratory syndrome coronavirus 2 in the South African population.
    J Virol Methods. 2022;307:114571.
    PubMed     Abstract available
    
    
    
32. AYADI W, Taktak A, Gargouri S, Smaoui F, et al
    Development of a simple genotyping method based on indel mutations to rapidly screen SARS-CoV-2 circulating variants: Delta, Omicron BA.1 and BA.2.
    J Virol Methods. 2022;307:114570.
    PubMed     Abstract available
    
    
    
33. ADAMS O, Andree M, Hermsen D, Lubke N, et al
    Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts.
    J Virol Methods. 2022;307:114569.
    PubMed     Abstract available
    
    
    
34. HONG Y, Guo H, Wei M, Zhang Y, et al
    Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.
    J Virol Methods. 2022;307:114564.
    PubMed     Abstract available
    
    
    
35. PABBARAJU K, Zelyas N, Wong A, Croxen MA, et al
    Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern.
    J Virol Methods. 2022;307:114553.
    PubMed     Abstract available
    
    
    August 2022
36. AZEEM S, Guo B, Sun D, Killian ML, et al
    Evaluation of PCR-Based Hemagglutinin Subtyping as a Tool to aid in Surveillance of Avian Influenza viruses in Migratory Wild Birds.
    J Virol Methods. 2022 Aug 2:114594. doi: 10.1016/j.jviromet.2022.114594.
    PubMed     Abstract available
    
    
    July 2022
37. DE OLIVEIRA PSS, de Oliveira Silva B, E Silva RP, Galdino LV, et al
    Evaluation of long-term stability of SARS-CoV-2 nucleic acid extracted from human nasopharyngeal samples.
    J Virol Methods. 2022;305:114529.
    PubMed     Abstract available
    
    
    June 2022
38. TAKUMI-TANIMUKAI Y, Yamamoto S, Ogasawara N, Nakabayashi S, et al
    A hydroxypropyl methylcellulose plaque assay for human respiratory syncytial virus.
    J Virol Methods. 2022;304:114528.
    PubMed     Abstract available
    
    
    
39. BARATHIDASAN R, Sharmila FM, Raj RV, Dhanalakshmi G, et al
    Pooled sample testing for COVID-19 diagnosis: Evaluation of bi-directional matrix pooling strategies.
    J Virol Methods. 2022;304:114524.
    PubMed     Abstract available
    
    
    
40. SRIVASTAVA S, Singh P, Malhotra R, Mathur P, et al
    Comparison of Abbott ID NOW, a novel isothermal amplification based COVID-19 diagnostic method with RTPCR.
    J Virol Methods. 2022;304:114521.
    PubMed     Abstract available
    
    
    
41. PENA B, Ochoa M, Flores O, Gil AI, et al
    Concordance in RT-PCR detection of SARS-CoV-2 between samples preserved in viral and bacterial transport medium.
    J Virol Methods. 2022;304:114522.
    PubMed     Abstract available
    
    
    
42. MORADZAD M, Soltani H, Salehi H, Rahmani K, et al
    A screening strategy for identifying the dominant variant of SARS-COV-2 in the fifth peak of Kurdistan- Iran population using HRM and Probe-based RT-PCR assay.
    J Virol Methods. 2022;304:114514.
    PubMed     Abstract available
    
    
    
43. BLOEMEN M, Rector A, Swinnen J, Ranst MV, et al
    Fast detection of SARS-CoV-2 variants including Omicron using one-step RT-PCR and Sanger sequencing.
    J Virol Methods. 2022;304:114512.
    PubMed     Abstract available
    
    
    
44. LEE SY, Lee JS, Ahn JJ, Kim SJ, et al
    Simultaneous detection of SARS-CoV-2 and identification of spike D614G mutation using point-of-care real-time polymerase chain reaction.
    J Virol Methods. 2022;304:114513.
    PubMed     Abstract available
    
    
    May 2022
45. ROSEN O, Jayson A, Dor E, Epstein E, et al
    SARS-CoV-2 spike antigen quantification by targeted mass spectrometry of a virus-based vaccine.
    J Virol Methods. 2022;303:114498.
    PubMed     Abstract available
    
    
    
46. BRITO-MUTUNAYAGAM S, Maloney D, McAllister G, Dewar R, et al
    Rapid detection of SARS-CoV-2 variants using allele-specific PCR.
    J Virol Methods. 2022;303:114497.
    PubMed     Abstract available
    
    
    April 2022
47. XU Y, Xia C, Zeng X, Qiu Y, et al
    Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein.
    J Virol Methods. 2022;302:114486.
    PubMed     Abstract available
    
    
    
48. ROSADAS C, Khan M, Parker E, Marchesin F, et al
    Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility.
    J Virol Methods. 2022;302:114475.
    PubMed     Abstract available
    
    
    
49. STIEBER F, Allen N, Carpenter K, Howard J, et al
    Accuracy of interferon gamma release assays for the COVID-19 immunity assessment.
    J Virol Methods. 2022;302:114472.
    PubMed     Abstract available
    
    
    
50. AHAVA MJ, Kurkela S, Kuivanen S, Lappalainen M, et al
    Detection of SARS-CoV-2 nucleocapsid antigen from serum can aid in timing of COVID-19 infection.
    J Virol Methods. 2022;302:114469.
    PubMed     Abstract available
    
    
    
51. VALLEY-OMAR Z, Marais G, Iranzadeh A, Naidoo M, et al
    Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests.
    J Virol Methods. 2022;302:114471.
    PubMed     Abstract available
    
    
    March 2022
52. AVELIN V, Sissonen S, Julkunen I, Osterlund P, et al
    Inactivation efficacy of H5N1 avian influenza virus by commonly used sample preparation reagents for safe laboratory practices.
    J Virol Methods. 2022 Mar 27:114527. doi: 10.1016/j.jviromet.2022.114527.
    PubMed     Abstract available
    
    
    
53. KANJI JN, Pabbaraju K, Wong A, Beitku C, et al
    Effect of not vortexing nasopharyngeal and throat swabs on SARS-CoV-2 nucleic acid detection: A pilot study.
    J Virol Methods. 2022;301:114468.
    PubMed     Abstract available
    
    
    
54. URRUTIKOETXEA-GUTIERREZ M, Toboso MCN, Zarraga EU, Aizpurua MM, et al
    Use of the Ct difference between the Nucleocapside (N) and the Spike (S) or RNA-dependent RNA polymerase (RdRP) genes as a preliminary screening for SARS-CoV-2 variants with the Allplex SARS-CoV-2/FluA/FluB/RSV Assay: Searching the N in Variants.
    J Virol Methods. 2022;301:114463.
    PubMed     Abstract available
    
    
    
55. CANPOLAT M, Bozkurt S, Sakalar C, Coban AY, et al
    Rapid thermal inactivation of aerosolized SARS-CoV-2.
    J Virol Methods. 2022;301:114465.
    PubMed     Abstract available
    
    
    
56. CAO XJ, Fang KY, Li YP, Zhou J, et al
    The Diagnostic Accuracy of Xpert Xpress to SARS-CoV-2: A systematic review.
    J Virol Methods. 2022;301:114460.
    PubMed     Abstract available
    
    
    
57. FU JYL, Chong YM, Sam IC, Chan YF, et al
    SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021.
    J Virol Methods. 2022;301:114462.
    PubMed     Abstract available
    
    
    
58. SCAPATICCI M, Bartolini A, Vitone F, Cerreta V, et al
    Detection of a characteristic melting profile of a SARS-CoV-2 Kappa variant in Italy using the SARS-CoV-2 Variants ELITe MGB(R) Kit.
    J Virol Methods. 2022;301:114458.
    PubMed     Abstract available
    
    
    
59. LI RH, Wang QY
    A localized small-scale external quality assessment (EQA) for PCR testing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the molecular laboratories.
    J Virol Methods. 2022;301:114441.
    PubMed     Abstract available
    
    
    
60. WU X, Chen Q, Li J, Liu Z, et al
    Diagnostic techniques for COVID-19: A mini-review.
    J Virol Methods. 2022;301:114437.
    PubMed     Abstract available
    
    
    
61. AGAOGLU NB, Yildiz J, Akgun Dogan O, Kose B, et al
    COVID-19 PCR test performance on samples stored at ambient temperature.
    J Virol Methods. 2022;301:114404.
    PubMed     Abstract available
    
    
    
62. SAXENA P, Nigam K, Mukherjee S, Chadha S, et al
    Relation of vitamin D to COVID-19.
    J Virol Methods. 2022;301:114418.
    PubMed     Abstract available
    
    
    
63. CHYON FA, Suman MNH, Fahim MRI, Ahmmed MS, et al
    Time series analysis and predicting COVID-19 affected patients by ARIMA model using machine learning.
    J Virol Methods. 2022;301:114433.
    PubMed     Abstract available
    
    
    
64. YU R, Li P
    Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking.
    J Virol Methods. 2022;301:114424.
    PubMed     Abstract available
    
    
    February 2022
65. P N, R N, B V, S R, et al
    COVID-19: Invasion, pathogenesis and possible cure - A review.
    J Virol Methods. 2022;300:114434.
    PubMed     Abstract available
    
    
    
66. KUMARI S, Raina A, Chandra D, Gupta N, et al
    Development and validation of novel kit for quantification of SARS-CoV-2 antibodies on clinical samples.
    J Virol Methods. 2022;300:114423.
    PubMed     Abstract available
    
    
    
67. BARROS FRO, Leite DCA, Guimaraes LJ, Lopes JMH, et al
    Performance of RT-qPCR detection of SARS-CoV-2 in unextracted nasopharyngeal samples using the Seegene Allplex(TM) 2019-nCoV protocol.
    J Virol Methods. 2022;300:114429.
    PubMed     Abstract available
    
    
    
68. BENSAADA M, Smaali MA, Bahi O, Bouhedjar K, et al
    Improvement of SARS-COV-2 screening using pooled sampling testing in limited RT-qPCR resources.
    J Virol Methods. 2022;300:114421.
    PubMed     Abstract available
    
    
    
69. FREEMAN J, Conklin J
    Standardization of two SARS-CoV-2 serology assays to the WHO 20/136 human standard reference material.
    J Virol Methods. 2022;300:114430.
    PubMed     Abstract available
    
    
    
70. CABRAL GB, Ahagon CM, de Souza Guimaraes PM, Silva Lopez-Lopes GI, et al
    Use of Sanger protocols to identify variants of concern, key mutations and track evolution of SARS-CoV-2.
    J Virol Methods. 2022;300:114422.
    PubMed     Abstract available
    
    
    
71. MARTIN RAMIREZ A, Zurita Cruz ND, Gutierrez-Cobos A, Rodriguez Serrano DA, et al
    Evaluation of two RT-PCR techniques for SARS-CoV-2 RNA detection in serum for microbiological diagnosis.
    J Virol Methods. 2022;300:114411.
    PubMed     Abstract available
    
    
    
72. TROBAJO-SANMARTIN C, Miqueleiz A, Portillo ME, Fernandez-Huerta M, et al
    Utility of a commercial RT-qPCR assay to detect SARS-CoV-2 gene variations as an indicator of lineages.
    J Virol Methods. 2022;300:114428.
    PubMed     Abstract available
    
    
    
73. MARTIN G, Rojo-Alba S, Castello-Abietar C, Abreu-Salinas F, et al
    Comparison of in-house SARS-CoV-2 genome extraction procedures. A need for COVID-19 pandemic.
    J Virol Methods. 2022;300:114415.
    PubMed     Abstract available
    
    
    
74. PIERRI B, Mancusi A, Proroga YTR, Capuano F, et al
    SARS-CoV-2 detection in nasopharyngeal swabs: Performance characteristics of a real-time RT-qPCR and a droplet digital RT-PCR assay based on the exonuclease region (ORF1b, nsp 14).
    J Virol Methods. 2022;300:114420.
    PubMed     Abstract available
    
    
    
75. POSSEBON FS, Ullmann LS, Malossi CD, Miodutzki GT, et al
    A fast and cheap in-house magnetic bead RNA extraction method for COVID-19 diagnosis.
    J Virol Methods. 2022;300:114414.
    PubMed     Abstract available
    
    
    
76. RANDRIAMAHAZO TR, Andrianarivelo AM, Rakotoarivo AT, Raheritiana TM, et al
    Evaluation of antigen-based rapid detection test for the diagnosis of SARS CoV-2 in low-income countries.
    J Virol Methods. 2022;300:114409.
    PubMed     Abstract available
    
    
    
77. PEZZUTO A, Tammaro A, Tonini G, Conforti G, et al
    SARS-Cov-2 pneumonia and concurrent myelodysplasia complicated by Pseudomonas aeruginosa over-infection.
    J Virol Methods. 2022;300:114419.
    PubMed     Abstract available
    
    
    
78. POPPING S, Molenkamp R, Weigel JD, Mutsaers PGNJ, et al
    Diminished amplification of SARS-CoV-2 ORF1ab in a commercial dual-target qRT-PCR diagnostic assay.
    J Virol Methods. 2022;300:114397.
    PubMed     Abstract available
    
    
    
79. MAK WA, Koeleman JGM, Ong DSY
    Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method.
    J Virol Methods. 2022;300:114398.
    PubMed     Abstract available
    
    
    
80. KWATRA G, Nunes M, Dhar N, Baillie V, et al
    Correlation of dried blood spots and plasma for quantification of Immunoglobulin (IgG) against Receptor binding domain and full length spike protein of SARS-CoV-2.
    J Virol Methods. 2022;300:114394.
    PubMed     Abstract available
    
    
    
81. PU R, Liu S, Ren X, Shi D, et al
    The screening value of RT-LAMP and RT-PCR in the diagnosis of COVID-19: systematic review and meta-analysis.
    J Virol Methods. 2022;300:114392.
    PubMed     Abstract available
    
    
    
82. MAK GCK, Ng AYY, Lam ETK, Chan RCW, et al
    Assessment of SARS-CoV-2 viral loads in combined nasal-and-throat swabs collected from COVID-19 individuals under the Universal Community Testing Programme in Hong Kong.
    J Virol Methods. 2022;300:114396.
    PubMed     Abstract available
    
    
    
83. FATHI KARKAN S, Maleki Baladi R, Shahgolzari M, Gholizadeh M, et al
    The evolving direct and indirect platforms for the detection of SARS-CoV-2.
    J Virol Methods. 2022;300:114381.
    PubMed     Abstract available
    
    
    
84. DE OLIVEIRA LPR, Cabral AD, Dos Santos Carmo AM, Duran AF, et al
    Alternative SARS-CoV-2 detection protocol from self-collected saliva for mass diagnosis and epidemiological studies in low-incoming regions.
    J Virol Methods. 2022;300:114382.
    PubMed     Abstract available
    
    
    
85. PEYRET H, Groppelli E, Clark D, Eckersley N, et al
    Production and use of encapsidated RNA mimics as positive control reagents for SARS-CoV-2 RT-qPCR diagnostics.
    J Virol Methods. 2022;300:114372.
    PubMed     Abstract available
    
    
    
86. AKRAM F, Haq IU, Aqeel A, Ahmed Z, et al
    Insights into the evolutionary and prophylactic analysis of SARS-CoV-2: A review.
    J Virol Methods. 2022;300:114375.
    PubMed     Abstract available
    
    
    
87. GARD L, Fliss MA, Bosma F, Ter Veen D, et al
    Validation and verification of the GeneFinder COVID-19 Plus RealAmp kit on the ELITe InGenius(R) instrument.
    J Virol Methods. 2022;300:114378.
    PubMed     Abstract available
    
    
    
88. GOMES L, Jeewandara C, Jayadas TP, Dissanayake O, et al
    Surveillance of SARS-CoV-2 variants of concern by identification of single nucleotide polymorphisms in the spike protein by a multiplex real-time PCR.
    J Virol Methods. 2022;300:114374.
    PubMed     Abstract available
    
    
    
89. MIZRAHI A, Nguyen Van JC, El Helali N, Lourtet-Hascoet J, et al
    The Coris BioConcept COVID 19 Ag Respi-Strip, a field experience feedback.
    J Virol Methods. 2022;300:114366.
    PubMed     Abstract available
    
    
    January 2022
90. OSHIRO S, Tabe Y, Funatogawa K, Saito K, et al
    Assessment of an immunochromatographic kit for detection of severe acute respiratory syndrome coronavirus 2 and influenza viruses.
    J Virol Methods. 2022 Jan 22:114477. doi: 10.1016/j.jviromet.2022.114477.
    PubMed     Abstract available
    
    
    
91. JAMES J, Seekings AH, Skinner P, Purchase K, et al
    Rapid and sensitive detection of high pathogenicity Eurasian clade 2.3.4.4b avian influenza viruses in wild birds and poultry.
    J Virol Methods. 2022;301:114454.
    PubMed     Abstract available
    
    
    
92. ZIMMERMANN F, Urban M, Kruger C, Walter M, et al
    In vitro evaluation of the effect of mutations in primer binding sites on detection of SARS-CoV-2 by RT-qPCR.
    J Virol Methods. 2022;299:114352.
    PubMed     Abstract available
    
    
    
93. DE CAMARGO BR, da Silva LA, de Oliveira AS, Ribeiro BM, et al
    An easy pipeline for one-step purification of SARS-CoV-2 nucleocapsid protein from insect cell suspension culture.
    J Virol Methods. 2022;299:114341.
    PubMed     Abstract available
    
    
    
94. HEANEY K, Ritchie AV, Henry R, Harvey AJ, et al
    Evaluation of sample pooling using the SAMBA II SARS-CoV-2 test.
    J Virol Methods. 2022;299:114340.
    PubMed     Abstract available
    
    
    
95. EHRET R, Breuer S, Dhein J, Reinhardt B, et al
    Clinical evaluation of the automated Abbott RealTime SARS-CoV-2, Alinity m SARS-CoV-2, and Alinity m Resp-4-Plex assays.
    J Virol Methods. 2022;299:114338.
    PubMed     Abstract available
    
    
    
96. BURDINO E, Cerutti F, Panero F, Allice T, et al
    SARS-CoV-2 microfluidic antigen point-of-care testing in Emergency Room patients during COVID-19 pandemic.
    J Virol Methods. 2022;299:114337.
    PubMed     Abstract available
    
    
    
97. HAILE S, Nikiforuk AM, Pandoh PK, Twa DDW, et al
    Optimization of magnetic bead-based nucleic acid extraction for SARS-CoV-2 testing using readily available reagents.
    J Virol Methods. 2022;299:114339.
    PubMed     Abstract available
    
    
    
98. CHAN CT, Leung JS, Lee LK, Lo HW, et al
    A low-cost TaqMan minor groove binder probe-based one-step RT-qPCR assay for rapid identification of N501Y variants of SARS-CoV-2.
    J Virol Methods. 2022;299:114333.
    PubMed     Abstract available
    
    
    
99. SCHIRTZINGER EE, Kim Y, Davis AS
    Improving human coronavirus OC43 (HCoV-OC43) research comparability in studies using HCoV-OC43 as a surrogate for SARS-CoV-2.
    J Virol Methods. 2022;299:114317.
    PubMed     Abstract available
    
    
    
100. SULEMAN S, Schrubaji K, Filippou C, Ignatova S, et al
     Rapid and inexpensive purification of adenovirus vectors using an optimised aqueous two-phase technology.
     J Virol Methods. 2022;299:114305.
     PubMed     Abstract available
     
     
     
101. BAKER CA, Gibson KE
     Phi 6 recovery from inoculated fingerpads based on elution buffer and methodology.
     J Virol Methods. 2022;299:114307.
     PubMed     Abstract available
     
     
     
102. LEE H, Lee TY, Jeon P, Kim N, et al
     J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases.
     J Virol Methods. 2022;299:114306.
     PubMed     Abstract available
     
     
     
103. KRUTTGEN A, Lauen M, Klingel H, Imohl M, et al
     Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273.
     J Virol Methods. 2022;299:114297.
     PubMed     Abstract available
     
     
     
104. WANG L, Ng TFF, Castro CJ, Marine RL, et al
     Next-generation sequencing of human respiratory syncytial virus subgroups A and B genomes.
     J Virol Methods. 2022;299:114335.
     PubMed     Abstract available
     
     
     December 2021
105. PEREIRA LA, Lapinscki BA, Debur MC, Santos JS, et al
     STANDARDIZATION OF A HIGH-PERFORMANCE RT-qPCR FOR VIRAL LOAD ABSOLUTE QUANTIFICATION OF INFLUENZA A.
     J Virol Methods. 2021 Dec 20:114439. doi: 10.1016/j.jviromet.2021.114439.
     PubMed     Abstract available
     
     
     
106. FEI C, Gao J, Fei C, Ma L, et al
     A flow-through chromatography purification process for Vero cell-derived influenza virus (H7N9).
     J Virol Methods. 2021 Dec 9:114408. doi: 10.1016/j.jviromet.2021.114408.
     PubMed     Abstract available
     
     
     
107. DELGADILLO-GUTIERREZ K, Castelan-Vega JA, Jimenez-Alberto A, Fernandez-Lizarraga MDC, et al
     Characterization and use in neutralization assays of avian influenza codon-optimized H5 and H7 retroviral pseudotypes.
     J Virol Methods. 2021;300:114391.
     PubMed     Abstract available
     
     
     
108. VILLOTA SD, Nipaz VE, Carrazco-Montalvo A, Hernandez S, et al
     Alternative RNA extraction-free techniques for the real-time RT-PCR detection of SARS-CoV-2 in nasopharyngeal swab and sputum samples.
     J Virol Methods. 2021;298:114302.
     PubMed     Abstract available
     
     
     
109. PAUL D, Gupta A, Rooge S, Gupta E, et al
     Performance evaluation of automated chemiluminescence immunoassay based antigen detection - Moving towards more reliable ways to predict SARS-CoV-2 infection.
     J Virol Methods. 2021;298:114299.
     PubMed     Abstract available
     
     
     
110. BOERS SA, Mourik BC, van Bussel MJAWM, de Brouwer CS, et al
     Increasing diagnostic possibilities using the geneLEAD VIII platform for detection of SARS-CoV-2.
     J Virol Methods. 2021;298:114291.
     PubMed     Abstract available
     
     
     
111. GUPTA A, Soni A, Rooge S, Paul D, et al
     Syndromic approach to SARS-CoV-2 detection using QIAstat-Dx SARS-CoV-2 panel from clinical samples.
     J Virol Methods. 2021;298:114300.
     PubMed     Abstract available
     
     
     
112. AUPAIX A, Lazarova E, Chemais M
     A brief performance evaluation and literature review of Abbott ID Now COVID-19 rapid molecular-based test.
     J Virol Methods. 2021;298:114293.
     PubMed     Abstract available
     
     
     
113. KRUTTGEN A, Klingel H, Haase G, Haefner H, et al
     Evaluation of the QuantiFERON SARS-CoV-2 interferon- release assay in mRNA-1273 vaccinated health care workers.
     J Virol Methods. 2021;298:114295.
     PubMed     Abstract available
     
     
     
114. MRAVINEC M, Bajc G, Butala M
     Surface plasmon resonance approach to study drug interactions with SARS-CoV-2 RNA-dependent RNA polymerase highlights treatment potential of suramin.
     J Virol Methods. 2021;298:114283.
     PubMed     Abstract available
     
     
     
115. VALLEJO L, Martinez-Rodriguez M, Nieto-Bazan MJ, Delgado-Iribarren A, et al
     Comparative study of different SARS-CoV-2 diagnostic techniques.
     J Virol Methods. 2021;298:114281.
     PubMed     Abstract available
     
     
     
116. KUMAR V, Ghosh K, Chandran A, Panwar S, et al
     Multicentric evaluation of a novel point of care electrochemical ELISA platform for SARS-CoV-2 specific IgG and IgM antibody assay.
     J Virol Methods. 2021;298:114275.
     PubMed     Abstract available
     
     
     
117. WANG D, Wang Z, Gao Y, Wu X, et al
     Validation of the analytical performance of nine commercial RT-qPCR kits for SARS-CoV-2 detection using certified reference material.
     J Virol Methods. 2021;298:114285.
     PubMed     Abstract available
     
     
     
118. DI CARLO D, Mazzuti L, Sciandra I, Guerrizio G, et al
     Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR kit 1.0 for the detection of SARS-CoV-2.
     J Virol Methods. 2021;298:114276.
     PubMed     Abstract available
     
     
     November 2021
119. CONG Y, Sun Y, Deng X, Yu H, et al
     A SYBR Green-based real-time RT-PCR assay to differentiate the H1N1 influenza virus lineages.
     J Virol Methods. 2021 Nov 27:114387. doi: 10.1016/j.jviromet.2021.114387.
     PubMed     Abstract available
     
     
     
120. XIANG H, Wen X, Wen Y, Zhang H, et al
     Development and application of a visual microarray for synchronously detecting H5N1, H7N9 and H9N2 avian influenza virus RNA.
     J Virol Methods. 2021 Nov 19:114371. doi: 10.1016/j.jviromet.2021.114371.
     PubMed     Abstract available
     
     
     
121. PEREIRA OLIVEIRA G, Kroon EG
     Mouse hepatitis virus: A betacoronavirus model to study the virucidal activity of air disinfection equipment on surface contamination.
     J Virol Methods. 2021;297:114274.
     PubMed     Abstract available
     
     
     
122. RIESTER E, Findeisen P, Hegel JK, Kabesch M, et al
     Performance evaluation of the Roche Elecsys Anti-SARS-CoV-2 S immunoassay.
     J Virol Methods. 2021;297:114271.
     PubMed     Abstract available
     
     
     
123. WEHRENDT DP, Masso MG, Gonzales Machuca A, Vargas CV, et al
     A rapid and simple protocol for concentration of SARS-CoV-2 from sewage.
     J Virol Methods. 2021;297:114272.
     PubMed     Abstract available
     
     
     
124. MANENTI A, Molesti E, Maggetti M, Torelli A, et al
     The theory and practice of the viral dose in neutralization assay: Insights on SARS-CoV-2 "doublethink" effect.
     J Virol Methods. 2021;297:114261.
     PubMed     Abstract available
     
     
     
125. SHAH SR, Kane SR, Elsheikh M, Alfaro TM, et al
     Development of a rapid viability RT-PCR (RV-RT-PCR) method to detect infectious SARS-CoV-2 from swabs.
     J Virol Methods. 2021;297:114251.
     PubMed     Abstract available
     
     
     
126. BARONTI C, Coutard B, de Lamballerie X, Charrel R, et al
     Evaluation of formulations to improve SARS-CoV-2 viability and thermostability after lyophilisation.
     J Virol Methods. 2021;297:114252.
     PubMed     Abstract available
     
     
     
127. SALVO M, Moller A, Alvareda E, Gamazo P, et al
     Evaluation of low-cost viral concentration methods in wastewaters: Implications for SARS-CoV-2 pandemic surveillances.
     J Virol Methods. 2021;297:114249.
     PubMed     Abstract available
     
     
     
128. BLAIRON L, Cupaiolo R, Piteus S, Beukinga I, et al
     The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another.
     J Virol Methods. 2021;297:114248.
     PubMed     Abstract available
     
     
     
129. CIESIELSKI M, Blackwood D, Clerkin T, Gonzalez R, et al
     Assessing sensitivity and reproducibility of RT-ddPCR and RT-qPCR for the quantification of SARS-CoV-2 in wastewater.
     J Virol Methods. 2021;297:114230.
     PubMed     Abstract available
     
     
     
130. MARIEN J, Michiels J, Heyndrickx L, Nkuba-Ndaye A, et al
     Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2.
     J Virol Methods. 2021;297:114228.
     PubMed     Abstract available
     
     
     October 2021
131. CHAINTOUTIS SC, Chassalevris T, Tsiolas G, Balaska S, et al
     A one-step real-time RT-PCR assay for simultaneous typing of SARS-CoV-2 mutations associated with the E484K and N501Y spike protein amino-acid substitutions.
     J Virol Methods. 2021;296:114242.
     PubMed     Abstract available
     
     
     
132. DE OLIVEIRA CM, Brochi L, Scarpelli LC, Lopes ACW, et al
     SARS-CoV-2 saliva testing is a useful tool for Covid-19 diagnosis.
     J Virol Methods. 2021;296:114241.
     PubMed     Abstract available
     
     
     
133. RAMOS A, Cardoso MJ, Norton P, Sarmento A, et al
     Serological response to a single dose of a SARS-CoV-2 mRNA vaccine.
     J Virol Methods. 2021;296:114223.
     PubMed     Abstract available
     
     
     
134. SHELITE TR, Uscanga-Palomeque AC, Castellanos-Gonzalez A, Melby PC, et al
     Isothermal recombinase polymerase amplification-lateral flow detection of SARS-CoV-2, the etiological agent of COVID-19.
     J Virol Methods. 2021;296:114227.
     PubMed     Abstract available
     
     
     
135. LAU CS, Hoo SP, Koh JMJ, Phua SK, et al
     Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.
     J Virol Methods. 2021;296:114224.
     PubMed     Abstract available
     
     
     
136. JAGTAP S, K R, Valloly P, Sharma R, et al
     Evaluation of spike protein antigens for SARS-CoV-2 serology.
     J Virol Methods. 2021;296:114222.
     PubMed     Abstract available
     
     
     
137. KIM YK, Chang SH
     Clinical usefulness of extraction-free PCR assay to detect SARS-CoV-2.
     J Virol Methods. 2021;296:114217.
     PubMed     Abstract available
     
     
     September 2021
138. KIM TY, Kim JY, Shim HJ, Yun SA, et al
     Comparison of the PowerChek SARS-CoV-2, Influenza A&B, RSV Multiplex Real-time PCR Kit and BioFire Respiratory Panel 2.1 for simultaneous detection of SARS-CoV-2, influenza A and B, and respiratory syncytial virus.
     J Virol Methods. 2021 Sep 27:114304. doi: 10.1016/j.jviromet.2021.114304.
     PubMed     Abstract available
     
     
     
139. ULLOA S, Bravo C, Ramirez E, Fasce R, et al
     Inactivation of SARS-CoV-2 isolates from lineages B.1.1.7 (Alpha), P.1 (Gamma) and B.1.110 by heating and UV irradiation.
     J Virol Methods. 2021;295:114216.
     PubMed     Abstract available
     
     
     
140. BROWN JR, O'Sullivan DM, Shah D, Atkinson L, et al
     Comparison of SARS-CoV-2 N gene real-time RT-PCR targets and commercially available mastermixes.
     J Virol Methods. 2021;295:114215.
     PubMed     Abstract available
     
     
     
141. CAMERO M, Lanave G, Catella C, Lucente MS, et al
     Evaluation of virucidal activity of fabrics using feline coronavirus.
     J Virol Methods. 2021;295:114214.
     PubMed     Abstract available
     
     
     
142. AVETYAN D, Chavushyan A, Ghazaryan H, Melkonyan A, et al
     SARS-CoV-2 detection by extraction-free qRT-PCR for massive and rapid COVID-19 diagnosis during a pandemic in Armenia.
     J Virol Methods. 2021;295:114199.
     PubMed     Abstract available
     
     
     
143. MALECKI M, Luesebrink J, Wendel AF, Mattner F, et al
     Analysis of external quality assessment samples revealed crucial performance differences between commercial RT-PCR assays for SARS-CoV-2 detection when taking extraction methods and real-time-PCR instruments into account.
     J Virol Methods. 2021;295:114202.
     PubMed     Abstract available
     
     
     
144. DUNDON WG, Settypalli TBK, Spiegel K, Steinrigl A, et al
     Comparison of eleven in vitro diagnostic assays for the detection of SARS-CoV-2 RNA.
     J Virol Methods. 2021;295:114200.
     PubMed     Abstract available
     
     
     
145. ORSI A, Pennati BM, Bruzzone B, Ricucci V, et al
     On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic.
     J Virol Methods. 2021;295:114201.
     PubMed     Abstract available
     
     
     
146. SUN Y, Ding C, Chen Q, Xie J, et al
     Digital PCR assay for the effective detection of COVID-19 patients with SARS-CoV-2 low viral load.
     J Virol Methods. 2021;295:114185.
     PubMed     Abstract available
     
     
     
147. ANANTHARAJAH A, Helaers R, Defour JP, Olive N, et al
     How to choose the right real-time RT-PCR primer sets for the SARS-CoV-2 genome detection?
     J Virol Methods. 2021;295:114197.
     PubMed     Abstract available
     
     
     
148. LEBLANC JJ, Pettipas J, Di Quinzio M, Hatchette TF, et al
     Reliable detection of SARS-CoV-2 with patient-collected swabs and saline gargles: A three-headed comparison on multiple molecular platforms.
     J Virol Methods. 2021;295:114184.
     PubMed     Abstract available
     
     
     August 2021
149. AYDIN S, Benk IG, Geckil AA
     May viral load detected in saliva in the early stages of infection be a prognostic indicator in COVID-19 patients?
     J Virol Methods. 2021;294:114198.
     PubMed     Abstract available
     
     
     
150. ROWAN AG, May P, Badhan A, Herrera C, et al
     Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control.
     J Virol Methods. 2021;294:114174.
     PubMed     Abstract available
     
     
     
151. OSHIRO S, Tabe Y, Funatogawa K, Saito K, et al
     Development of an immunochromatographic kit to detect severe acute respiratory syndrome coronavirus 2.
     J Virol Methods. 2021;294:114183.
     PubMed     Abstract available
     
     
     
152. DUCREST PJ, Freymond A, Segura JM
     Performance evaluation of the Simtomax(R) CoronaCheck rapid diagnostic test.
     J Virol Methods. 2021;294:114178.
     PubMed     Abstract available
     
     
     
153. SANDOVAL TORRIENTES M, Castello Abietar C, Boga Riveiro J, Alvarez-Arguelles ME, et al
     A novel single nucleotide polymorphism assay for the detection of N501Y SARS-CoV-2 variants.
     J Virol Methods. 2021;294:114143.
     PubMed     Abstract available
     
     
     July 2021
154. FINCH J, Zuckerman M, Smith M
     Investigating the sequence variation in the influenza A matrix genes during the 2017-2018 and 2018-2019 seasons in samples from a local population in London.
     J Virol Methods. 2021;297:114250.
     PubMed     Abstract available
     
     
     
155. BUBONJA-SONJE M, Baticic L, Abram M, Cekinovic Grbesa D, et al
     Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies.
     J Virol Methods. 2021;293:114173.
     PubMed     Abstract available
     
     
     
156. APOSTOLOU T, Kyritsi M, Vontas A, Loizou K, et al
     Development and performance characteristics evaluation of a new Bioelectric Recognition Assay (BERA) method for rapid Sars-CoV-2 detection in clinical samples.
     J Virol Methods. 2021;293:114166.
     PubMed     Abstract available
     
     
     
157. KENYERES B, Anosi N, Banyai K, Matyus M, et al
     Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2.
     J Virol Methods. 2021;293:114165.
     PubMed     Abstract available
     
     
     
158. LU X, Sakthivel SK, Wang L, Lynch B, et al
     Enhanced throughput of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time RT-PCR panel by assay multiplexing and specimen pooling.
     J Virol Methods. 2021;293:114149.
     PubMed     Abstract available
     
     
     
159. PORTAKAL SH, Kanat B, Sayan M, Berber B, et al
     A novel method for conserved sequence extraction with prospective mutation prediction for SARS-CoV-2 PCR primer design.
     J Virol Methods. 2021;293:114146.
     PubMed     Abstract available
     
     
     
160. NOOR FA, Safain KS, Hossain MW, Arafath K, et al
     Development and performance evaluation of the first in-house multiplex rRT-PCR assay in Bangladesh for highly sensitive detection of SARS-CoV-2.
     J Virol Methods. 2021;293:114147.
     PubMed     Abstract available
     
     
     
161. WANG X, Huang Z, Song J, Xiao Y, et al
     Analytical sensitivity comparison of 14 conventional and three rapid RT-PCR assays for SARS-CoV-2 detection.
     J Virol Methods. 2021;293:114144.
     PubMed     Abstract available
     
     
     
162. MALLMANN L, Hermann BS, Schallenberger K, Demoliner M, et al
     Proteinase K treatment in absence of RNA isolation classical procedures is a quick and cheaper alternative for SARS-CoV-2 molecular detection.
     J Virol Methods. 2021;293:114131.
     PubMed     Abstract available
     
     
     
163. RAMANI R, Laplante JM, Church TM, Farrell GM, et al
     CACO-2 cells: A continuous cell line with sensitive and broad-spectrum utility for respiratory virus culture.
     J Virol Methods. 2021;293:114120.
     PubMed     Abstract available
     
     
     June 2021
164. LIANG Y, Yan H, Huang L, Zhao J, et al
     A luciferase immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 nucleoprotein.
     J Virol Methods. 2021;292:114141.
     PubMed     Abstract available
     
     
     
165. SOLEIMANI R, Khourssaji M, Aupaix A, Rodriguez-Villalobos H, et al
     Usefulness of a multiplex immunodot in case of discordant results between automated COVID-19 serological assays.
     J Virol Methods. 2021;292:114129.
     PubMed     Abstract available
     
     
     
166. MULLER K, Girl P, von Buttlar H, Dobler G, et al
     Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2.
     J Virol Methods. 2021;292:114122.
     PubMed     Abstract available
     
     
     
167. PARAI D, Dash GC, Choudhary HR, Peter A, et al
     Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies.
     J Virol Methods. 2021;292:114121.
     PubMed     Abstract available
     
     
     
168. TELWATTE S, Kumar N, Vallejo-Gracia A, Kumar GR, et al
     Novel RT-ddPCR assays for simultaneous quantification of multiple noncoding and coding regions of SARS-CoV-2 RNA.
     J Virol Methods. 2021;292:114115.
     PubMed     Abstract available
     
     
     May 2021
169. DAWSON ED, Kuck LR, Blair RH, Taylor AW, et al
     Multiplexed, microscale, microarray-based serological assay for antibodies against all human-relevant coronaviruses.
     J Virol Methods. 2021;291:114111.
     PubMed     Abstract available
     
     
     
170. KOHMER N, Rabenau HF, Hoehl S, Kortenbusch M, et al
     Comparative analysis of point-of-care, high-throughput and laboratory-developed SARS-CoV-2 nucleic acid amplification tests (NATs).
     J Virol Methods. 2021;291:114102.
     PubMed     Abstract available
     
     
     
171. BLAND J, Kavanaugh A, Hong LK, Kadkol SS, et al
     Development and validation of viral load assays to quantitate SARS-CoV-2.
     J Virol Methods. 2021;291:114100.
     PubMed     Abstract available
     
     
     
172. VISSEAUX B, Collin G, Houhou-Fidouh N, Le Hingrat Q, et al
     Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements.
     J Virol Methods. 2021;291:114086.
     PubMed     Abstract available
     
     
     April 2021
173. DANILENKO DM, Eropkin MY, Leonenko VN, Konovalova NI, et al
     Assessment of rat polyclonal antisera's suitability in hemagglutination inhibition assay for influenza surveillance and antigenic mapping.
     J Virol Methods. 2021;293:114170.
     PubMed     Abstract available
     
     
     
174. PABBARAJU K, Wong AA, Ma R, Zelyas N, et al
     Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2.
     J Virol Methods. 2021 Apr 8:114151. doi: 10.1016/j.jviromet.2021.114151.
     PubMed    
     
     
     
175. NIMSAMER P, Mayuramart O, Rattanaburi S, Chantaravisoot N, et al
     Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens.
     J Virol Methods. 2021;290:114092.
     PubMed     Abstract available
     
     
     
176. ZWIRGLMAIER K, Weyh M, Kruger C, Ehmann R, et al
     Rapid detection of SARS-CoV-2 by pulse-controlled amplification (PCA).
     J Virol Methods. 2021;290:114083.
     PubMed     Abstract available
     
     
     
177. BURTON J, Love H, Richards K, Burton C, et al
     The effect of heat-treatment on SARS-CoV-2 viability and detection.
     J Virol Methods. 2021;290:114087.
     PubMed     Abstract available
     
     
     
178. OLADUNNI FS, Park JG, Chiem K, Ye C, et al
     Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
     J Virol Methods. 2021;290:114084.
     PubMed     Abstract available
     
     
     
179. PERE H, Mboumba Bouassa RS, Tonen-Wolyec S, Podglajen I, et al
     Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
     J Virol Methods. 2021;290:114067.
     PubMed     Abstract available
     
     
     
180. TOZETTO-MENDOZA TR, Kanunfre KA, Vilas-Boas LS, Sanchez Espinoza EP, et al
     Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
     J Virol Methods. 2021;290:114064.
     PubMed     Abstract available
     
     
     
181. DOGAN OA, Kose B, Agaoglu NB, Yildiz J, et al
     Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs.
     J Virol Methods. 2021;290:114049.
     PubMed     Abstract available
     
     
     
182. HON KL, Leung KKY, Tang JW, Leung AKC, et al
     COVID-19 in Hong Kong - Public health, food safety, and animal vectors perspectives.
     J Virol Methods. 2021;290:114036.
     PubMed     Abstract available
     
     
     March 2021
183. LEE J, Cho AY, Ko HH, Ping JF, et al
     Evaluation of insulated isothermal PCR devices for the detection of avian influenza virus.
     J Virol Methods. 2021 Mar 9:114126. doi: 10.1016/j.jviromet.2021.114126.
     PubMed     Abstract available
     
     
     
184. JORGENSEN RL, Pedersen MS, Chauhan AS, Andreasson LM, et al
     An in-well direct lysis method for rapid detection of SARS-CoV-2 by real time RT-PCR in eSwab specimens.
     J Virol Methods. 2021;289:114062.
     PubMed     Abstract available
     
     
     
185. CATRY E, Jacqmin H, Dodemont M, Saad Albichr I, et al
     Analytical and clinical evaluation of four commercial SARS-CoV-2 serological immunoassays in hospitalized patients and ambulatory individuals.
     J Virol Methods. 2021;289:114060.
     PubMed     Abstract available
     
     
     
186. HOWSON ELA, Kidd SP, Armson B, Goring A, et al
     Preliminary optimisation of a simplified sample preparation method to permit direct detection of SARS-CoV-2 within saliva samples using reverse-transcription loop-mediated isothermal amplification (RT-LAMP).
     J Virol Methods. 2021;289:114048.
     PubMed     Abstract available
     
     
     
187. BASU I, Nagappan R, Fox-Lewis S, Muttaiyah S, et al
     Evaluation of extraction and amplification assays for the detection of SARS-CoV-2 at Auckland Hospital laboratory during the COVID-19 outbreak in New Zealand.
     J Virol Methods. 2021;289:114042.
     PubMed     Abstract available
     
     
     
188. PEREZ-GARCIA F, Perez-Tanoira R, Iglesias ME, Romanyk J, et al
     Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2.
     J Virol Methods. 2021;289:114047.
     PubMed     Abstract available
     
     
     
189. LAGOPATI N, Tsioli P, Mourkioti I, Polyzou A, et al
     Sample pooling strategies for SARS-CoV-2 detection.
     J Virol Methods. 2021;289:114044.
     PubMed     Abstract available
     
     
     
190. TANG JW
     SARS-CoV-2 and aerosols-Arguing over the evidence.
     J Virol Methods. 2021;289:114033.
     PubMed     Abstract available
     
     
     
191. PEREIRA-GOMEZ M, Fajardo A, Echeverria N, Lopez-Tort F, et al
     Evaluation of SYBR Green real time PCR for detecting SARS-CoV-2 from clinical samples.
     J Virol Methods. 2021;289:114035.
     PubMed     Abstract available
     
     
     
192. VELASCO JM, Shrestha S, Valderama MT, Shrestha J, et al
     A multi-country field validation of the FluChip-8G Insight Assay.
     J Virol Methods. 2021;289:114029.
     PubMed     Abstract available
     
     
     February 2021
193. XIAO Y, Li Z, Wang X, Wang Y, et al
     Comparison of three TaqMan real-time reverse transcription-PCR assays in detecting SARS-CoV-2.
     J Virol Methods. 2021;288:114030.
     PubMed     Abstract available
     
     
     
194. VON RHEIN C, Scholz T, Henss L, Kronstein-Wiedemann R, et al
     Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma.
     J Virol Methods. 2021;288:114031.
     PubMed     Abstract available
     
     
     
195. KRUTTGEN A, Cornelissen CG, Dreher M, Hornef MW, et al
     Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit.
     J Virol Methods. 2021;288:114024.
     PubMed     Abstract available
     
     
     
196. MARIEN J, Ceulemans A, Michiels J, Heyndrickx L, et al
     Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.
     J Virol Methods. 2021;288:114025.
     PubMed     Abstract available
     
     
     
197. SILVA JUNIOR JVJ, Merchioratto I, de Oliveira PSB, Rocha Lopes TR, et al
     End-point RT-PCR: A potential alternative for diagnosing coronavirus disease 2019 (COVID-19).
     J Virol Methods. 2021;288:114007.
     PubMed     Abstract available
     
     
     January 2021
198. AMBROSI C, Prezioso C, Checconi P, Scribano D, et al
     SARS-CoV-2: Comparative analysis of different RNA extraction methods.
     J Virol Methods. 2021;287:114008.
     PubMed     Abstract available
     
     
     
199. DU J, Chu E, Zhang D, Lu CM, et al
     A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19.
     J Virol Methods. 2021;287:114009.
     PubMed     Abstract available
     
     
     
200. KULKARNI R, Patil HP, Palkar S, Lalwani S, et al
     Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using beta-propiolactone-inactivated, whole virus-based indirect ELISA.
     J Virol Methods. 2021;287:113996.
     PubMed     Abstract available
     
     
     
201. PARK JG, Oladunni FS, Chiem K, Ye C, et al
     Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
     J Virol Methods. 2021;287:113995.
     PubMed     Abstract available
     
     
     
202. KRUTTGEN A, Cornelissen CG, Dreher M, Hornef MW, et al
     Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
     J Virol Methods. 2021;287:113978.
     PubMed     Abstract available
     
     
     
203. BELTRAN-PAVEZ C, Alonso-Palomares LA, Valiente-Echeverria F, Gaggero A, et al
     Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction.
     J Virol Methods. 2021;287:113969.
     PubMed     Abstract available
     
     
     December 2020
204. KODE SS, Pawar SD, Tare DS, Mullick J, et al
     Application of frozen and stored glutaraldehyde-fixed Turkey red blood cells for hemagglutination and hemagglutination inhibition assays for the detection and identification of influenza viruses.
     J Virol Methods. 2020 Dec 14:114046. doi: 10.1016/j.jviromet.2020.114046.
     PubMed     Abstract available
     
     
     
205. ROCCA MF, Zintgraff JC, Dattero ME, Santos LS, et al
     A combined approach of MALDI-TOF mass spectrometry and multivariate analysis as a potential tool for the detection of SARS-CoV-2 virus in nasopharyngeal swabs.
     J Virol Methods. 2020;286:113991.
     PubMed     Abstract available
     
     
     
206. ALEXANDER MR, Rootes CL, van Vuren PJ, Stewart CR, et al
     Concentration of infectious SARS-CoV-2 by polyethylene glycol precipitation.
     J Virol Methods. 2020;286:113977.
     PubMed     Abstract available
     
     
     
207. LIU M, Li Q, Zhou J, Ai W, et al
     Value of swab types and collection time on SARS-COV-2 detection using RT-PCR assay.
     J Virol Methods. 2020;286:113974.
     PubMed     Abstract available
     
     
     
208. MOHON AN, Oberding L, Hundt J, van Marle G, et al
     Optimization and clinical validation of dual-target RT-LAMP for SARS-CoV-2.
     J Virol Methods. 2020;286:113972.
     PubMed     Abstract available
     
     
     
209. MICHEL D, Danzer KM, Gross R, Conzelmann C, et al
     Rapid, convenient and efficient kit-independent detection of SARS-CoV-2 RNA.
     J Virol Methods. 2020;286:113965.
     PubMed     Abstract available
     
     
     November 2020
210. BAKRE A, Jones L, Bennett HK, Bobbitt D, et al
     Detection of Swine Influenza Virus in Nasal Specimens by Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP).
     J Virol Methods. 2020 Nov 30:114015. doi: 10.1016/j.jviromet.2020.114015.
     PubMed     Abstract available
     
     
     
211. SEIBERT B, Angel M, Caceres CJ, Sutton T, et al
     DEVELOPMENT OF A SWINE RNA POLYMERASE I DRIVEN INFLUENZA REVERSE GENETICS SYSTEM FOR THE RESCUE OF TYPE A AND B INFLUENZA VIRUSES.
     J Virol Methods. 2020 Nov 2:114011. doi: 10.1016/j.jviromet.2020.114011.
     PubMed     Abstract available
     
     
     
212. DUST K, Hedley A, Nichol K, Stein D, et al
     Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2.
     J Virol Methods. 2020;285:113970.
     PubMed     Abstract available
     
     
     
213. ULLOA S, Bravo C, Parra B, Ramirez E, et al
     A simple method for SARS-CoV-2 detection by rRT-PCR without the use of a commercial RNA extraction kit.
     J Virol Methods. 2020;285:113960.
     PubMed     Abstract available
     
     
     
214. PATRIQUIN G, Davis I, Heinstein C, MacDonald J, et al
     Exploring alternative swabs for use in SARS-CoV-2 detection from the oropharynx and anterior nares.
     J Virol Methods. 2020;285:113948.
     PubMed     Abstract available
     
     
     
215. GARNETT L, Bello A, Tran KN, Audet J, et al
     Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages.
     J Virol Methods. 2020;285:113947.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: